1,487
Views
28
CrossRef citations to date
0
Altmetric
Brief Report

In vivo correlates of molecularly inferred virulence among extraintestinal pathogenic Escherichia coli (ExPEC) in the wax moth Galleria mellonella model system

, , , &
Pages 388-393 | Received 17 Jul 2013, Accepted 20 Jan 2014, Published online: 11 Feb 2014

References

  • Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 2003; 5:449 - 56; http://dx.doi.org/10.1016/S1286-4579(03)00049-2; PMID: 12738001
  • Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli.. Nat Rev Microbiol 2004; 2:123 - 40; http://dx.doi.org/10.1038/nrmicro818; PMID: 15040260
  • Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis 2004; 190:2121 - 8; http://dx.doi.org/10.1086/425984; PMID: 15551210
  • Zhang L, Foxman B, Marrs C. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol 2002; 40:3951 - 5; http://dx.doi.org/10.1128/JCM.40.11.3951-3955.2002; PMID: 12409357
  • Köhler CD, Dobrindt U. What defines extraintestinal pathogenic Escherichia coli?. Int J Med Microbiol 2011; 301:642 - 7; http://dx.doi.org/10.1016/j.ijmm.2011.09.006; PMID: 21982038
  • Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli.. Int J Med Microbiol 2005; 295:383 - 404; http://dx.doi.org/10.1016/j.ijmm.2005.07.005; PMID: 16238015
  • Johnson JR, Johnston B, Clabots C, Kuskowski MA, Pendyala S, Debroy C, Nowicki B, Rice J. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother 2010; 54:546 - 50; http://dx.doi.org/10.1128/AAC.01089-09; PMID: 19917759
  • Glavis-Bloom J, Muhammed M, Mylonakis E. Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research. Adv Exp Med Biol 2012; 710:11 - 7; http://dx.doi.org/10.1007/978-1-4419-5638-5_2; PMID: 22127881
  • Fuchs BB, O’Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010; 1:475 - 82; http://dx.doi.org/10.4161/viru.1.6.12985; PMID: 21178491
  • Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr., Mylonakis E. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53:2605 - 9; http://dx.doi.org/10.1128/AAC.01533-08; PMID: 19332683
  • Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr., Eliopoulos GM. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 2009; 199:532 - 6; http://dx.doi.org/10.1086/596511; PMID: 19125671
  • Inglis RF, Gardner A, Cornelis P, Buckling A. Spite and virulence in the bacterium Pseudomonas aeruginosa.. Proc Natl Acad Sci U S A 2009; 106:5703 - 7; http://dx.doi.org/10.1073/pnas.0810850106; PMID: 19321425
  • Chua KY, Seemann T, Harrison PF, Monagle S, Korman TM, Johnson PD, Coombs GW, Howden BO, Davies JK, Howden BP, et al. The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One 2011; 6:e25887; http://dx.doi.org/10.1371/journal.pone.0025887; PMID: 21991381
  • Leuko S, Raivio TL. Mutations that impact the enteropathogenic Escherichia coli Cpx envelope stress response attenuate virulence in Galleria mellonella.. Infect Immun 2012; 80:3077 - 85; http://dx.doi.org/10.1128/IAI.00081-12; PMID: 22710873
  • Williamson DA, Freeman JT, Porter S, Roberts S, Wiles S, Paterson DL, Johnson JR. Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy. J Antimicrob Chemother 2013; 68:2898 - 906; http://dx.doi.org/10.1093/jac/dkt276; PMID: 23833184
  • Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 2012; 80:1554 - 62; http://dx.doi.org/10.1128/IAI.06388-11; PMID: 22311928
  • Williamson DA, Roberts SA, Paterson DL, Sidjabat H, Silvey A, Masters J, Rice M, Freeman JT. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. Clin Infect Dis 2012; 54:1406 - 12; http://dx.doi.org/10.1093/cid/cis194; PMID: 22419681
  • Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, et al. The complete genome sequence of Escherichia coli K-12. Science 1997; 277:1453 - 62; http://dx.doi.org/10.1126/science.277.5331.1453; PMID: 9278503
  • Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009; 53:2733 - 9; http://dx.doi.org/10.1128/AAC.00297-09; PMID: 19398649